Voximetry

Voximetry is a Healthtech software and services company based in Madison, Wisconsin, founded in 2016. The company specializes in advanced, patient-specific radiopharmaceutical therapy dosimetry and personalized cancer treatment. Its core product, Torch® Dose Assessment, is a proprietary software platform that utilizes artificial intelligence, Monte Carlo algorithms, and high-speed GPU computing to deliver accurate dosimetry for radiopharmaceutical therapies. This technology allows clinicians to create individualized treatment plans, particularly for advanced-stage cancer patients. In addition to its software, Voximetry provides advanced dosimetry support for clinical trials, partnering with organizations like Medpace Core Laboratories. This collaboration enhances clinical trial rigor and operational efficiency by integrating precise dosimetry with comprehensive contract research organization services. Voximetry is also expanding its reach into the EMEA and APAC markets, with plans for international growth and regulatory milestones, including obtaining a CE mark for commercialization in Europe and Asia. The company is committed to advancing safe, individualized cancer treatment through innovative dosimetry technology.

• Employees 19
• Founded 2016